Chimeric Therapeutics Ltd. (AU:CHM) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Chimeric Therapeutics Ltd. has announced the issuance of 55 million unquoted equity securities, set to expire on various dates, indicating an active move in the capital markets. This development could influence the company’s stock activity on the ASX, drawing attention from investors focused on biotech innovations.
For further insights into AU:CHM stock, check out TipRanks’ Stock Analysis page.